John R. Stuelpnagel - 01 Jul 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
01 Jul 2021
Net transactions value
-$958,215
Form type
4
Filing time
06 Jul 2021, 16:30:45 UTC
Previous filing
21 Jun 2021
Next filing
20 Jul 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $303,909 -1,600 -0.4% $189.94 400,016 01 Jul 2021 Direct F1, F2
transaction TXG Class A Common Stock Sale $248,127 -1,300 -0.32% $190.87 398,716 01 Jul 2021 Direct F1, F3
transaction TXG Class A Common Stock Sale $134,381 -700 -0.18% $191.97 398,016 01 Jul 2021 Direct F1, F4
transaction TXG Class A Common Stock Sale $135,454 -700 -0.18% $193.51 397,316 01 Jul 2021 Direct F1, F5
transaction TXG Class A Common Stock Sale $97,143 -500 -0.13% $194.29 396,816 01 Jul 2021 Direct F1, F6
transaction TXG Class A Common Stock Sale $39,200 -200 -0.05% $196.00 396,616 01 Jul 2021 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $189.385 to $190.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $190.40 to $191.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $191.46 to $192.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $193.02 to $193.82. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $194.03 to $194.64. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This transaction was executed in multiple trades at prices ranging from $195.82 to $196.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.